ScholarIQanswers from OpenAlex & ORCID
James L. Kirkland
ResearcherPublications, citations & collaboration network
James L. Kirkland is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James L. Kirkland have?
ScholarIQindexed works
James L. Kirkland has 497 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James L. Kirkland have?
ScholarIQcitation count
James L. Kirkland has 62,443 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James L. Kirkland?
ScholarIQh-index
James L. Kirkland has an h-index of 113 in OpenAlex.
What is the i10-index of James L. Kirkland?
ScholarIQi10-index
James L. Kirkland has an i10-index of 301 in OpenAlex.
What is the ORCID of James L. Kirkland?
ScholarIQorcid
The ORCID for James L. Kirkland is on the source record.
What is the OpenAlex record for James L. Kirkland?
ScholarIQopenalex
The OpenAlex for James L. Kirkland is on the source record.
What are the most-cited papers on James L. Kirkland?
ScholarIQmost cited works
Senolytics improve physical function and increase lifespan in old age
Ming Xu, Tamar Pirtskhalava, Joshua N. Farr, Bettina M. Weigand, Allyson K. Palmer, Megan Weivoda, Christina L. Inman, Mikołaj Ogrodnik, Christine Hachfeld, Daniel G. Fraser, Jennifer L Onken, Kurt O. Johnson, Grace Verzosa, Larissa G. P. Langhi, Moritz Weigl, Nino Giorgadze, Nathan K. LeBrasseur, Jordan D. Miller, Diana Jurk, Ravinder J. Singh, David B. Allison, Keisuke Ejima, Gene B. Hubbard, Yuji Ikeno, Hajrunisa Čubro, Vesna D. Garovic, Xiaonan Hou, S. John Weroha, Paul D. Robbins, Laura J. Niedernhofer, Sundeep Khosla, Tamar Tchkonia, James L. Kirkland
Targeting cellular senescence prevents age-related bone loss in mice
Joshua N. Farr, Ming Xu, Megan Weivoda, David G. Monroe, Daniel G. Fraser, Jennifer L Onken, Brittany A Negley, Jad Sfeir, Mikołaj Ogrodnik, Christine Hachfeld, Nathan K. LeBrasseur, Matthew T. Drake, Robert J. Pignolo, Tamar Pirtskhalava, Tamar Tchkonia, Merry Jo Oursler, James L. Kirkland, Sundeep Khosla
Fisetin is a senotherapeutic that extends health and lifespan
Matthew J. Yousefzadeh, Yi Zhu, Sara J. McGowan, Luise Angelini, Heike Fuhrmann‐Stroissnigg, Ming Xu, Yuan Yuan Ling, Kendra I. Melos, Tamar Pirtskhalava, Christina L. Inman, Collin A. McGuckian, Erin A. Wade, Jonathon I. Kato, Diego Grassi, Mark Wentworth, Christin E. Burd, Edgar A. Arriaga, Warren Ladiges, Tamar Tchkonia, James L. Kirkland, Paul D. Robbins, Laura J. Niedernhofer
JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age
Ming Xu, Tamar Tchkonia, Husheng Ding, Mikołaj Ogrodnik, Ellen R. Lubbers, Tamar Pirtskhalava, Thomas A. White, Kurt O. Johnson, Michael B. Stout, Vojtěch Mezera, Nino Giorgadze, Michael D. Jensen, Nathan K. LeBrasseur, James L. Kirkland
Targeting senescent cells alleviates obesity‐induced metabolic dysfunction
Allyson K. Palmer, Ming Xu, Yi Zhu, Tamar Pirtskhalava, Megan Weivoda, Christine Hachfeld, Larissa Prata, Theo H. van Dijk, Esther Verkade, Grace Casaclang‐Verzosa, Kurt O. Johnson, Hajrunisa Čubro, Ewald J. Doornebal, Mikołaj Ogrodnik, Diana Jurk, Michael D. Jensen, Eduardo N. Chini, Jordan D. Miller, Aleksey V. Matveyenko, Michael B. Stout, Marissa Schafer, Thomas A. White, LaTonya J. Hickson, Marco Demaria, Vesna D. Garovic, Joseph P. Grande, Edgar A. Arriaga, Folkert Kuipers, Thomas von Zglinicki, Nathan K. LeBrasseur, Judith Campisi, Tamar Tchkonia, James L. Kirkland